HighTower Advisors
RMD icon

HighTower Advisors’s ResMed RMD Stock Holding History

HighTower Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$585 – 4002
2024
Q4 		$585 Hold
100
– – ﹤0.01% 3727
2024
Q3 		$2.95K Buy
+100
New +$22.3K ﹤0.01% 3618
2020
Q2 		– Sell
-100
Closed -$2K – 2521
2020
Q1 		$2K Buy
+100
New +$15.9K ﹤0.01% 2182

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HighTower Advisors's RMD Position: Q2 2026 in Review

HighTower Advisors reduced its ResMed (RMD) stake by 22% in Q2 2026, selling an estimated $943K and leaving 16,475 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

HighTower Advisors first reported a position in RMD in Q1 2014 and has held it in 48 quarters since. The position peaked at $19.9M in Q4 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • HighTower Advisors held 16,475 shares of ResMed worth $3.21M as of Q2 2026.
  • HighTower Advisors sold 4,550 ResMed shares in Q2 2026, an estimated $943K.
  • ResMed made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1491 holding.
  • HighTower Advisors first reported a position in ResMed in Q1 2014 and has held it in 48 quarters since.
  • HighTower Advisors's ResMed position peaked at $19.9M in Q4 2021.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.